Recall: D-0112-2025

Class II - Potentially Harmful

Class IIClassification
2024-10-25Initiated
TerminatedStatus
Lannett Company Inc.Firm

Product

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

Reason

Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.